Author:
Ellerington M. C.,Whitcroft S. I. J.,Whitehead M. I.
Reference53 articles.
1. Campbell S, Whitehead MI. Potency and hepatocellular effects of oestrogens. In: van Keep PA, Utian WH, Vermulen A, eds. The Controversial Climacteric. Lancaster: MTP Press; 1982: 102–25.
2. Dusterberg B, Schhmidt-Gollwitzer M, Humpel M. Pharmacokinetics and biotransformation of estradiol valerate in ovariectomised women. Hormone Res. 1985; 21: 145–54.
3. Laragh JH, Seeley JE, Leddinghum JG, Newton MA. Oral contraceptives; renin, aldosterone and high blood pressure. J Am Med Assoc. 1967; 201: 918–22.
4. Campbell S, Whitehead MI. Oestrogen therapy and the menopausal syndrome. In: Greenblatt RB, Studd JWW, eds. The Menopause: Clinics in Obstetrics and Gynecology, vol 4 No 1 Philadelphia: Saunders; 1977: 31–47.
5. Boston Collaborative Drug Surveillance Programme. Surgically confirmed gall bladder disease, venous thrombo-embolism and breast tumours in relation to postmenopausal estrogen therapy. N Eng J Med. 1974; 290: 15.